Ixekizumab, CAS [[1143503-69-8]]

Produktübersicht

• Artikelname: Ixekizumab, CAS [[1143503-69-8]]
• Artikelnummer: TGM-T38105
• Hersteller Artikelnummer: T38105
• Alternativnummer: TGM-T38105-1MG,TGM-T38105-5MG,TGM-T38105-10MG,TGM-T38105-25MG,TGM-T38105-50MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: LY2439821

Produktbeschreibung

Ixekizumab (LY2439821) is a humanized IgG4 monoclonal antibody that selectively binds and neutralizes interleukin IL-17A with a Kd value of <3 pM. It blocks the binding of IL-17A to IL-17RA but not to other IL-17 family members. Ixekizumab is used for the treatment of moderate to severe plaque psoriasis, psoriasis, arthritis, and psoriasis.

Produkteigenschaften

• Reinheit: 95.00%
• CAS Nummer: [1143503-69-8]
• Target-Kategorie: IL Receptor|||Interleukin

Bilder

T38105